Eugia Pharma Speclts Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA SPECLTS, and what generic alternatives to EUGIA PHARMA SPECLTS drugs are available?
EUGIA PHARMA SPECLTS has eighteen approved drugs.
There is one US patent protecting EUGIA PHARMA SPECLTS drugs. There are two tentative approvals on EUGIA PHARMA SPECLTS drugs.
There are ten patent family members on EUGIA PHARMA SPECLTS drugs in nine countries and one supplementary protection certificate in one country.
Summary for Eugia Pharma Speclts
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 12 |
| Ingredients: | 12 |
| NDAs: | 18 |
Drugs and US Patents for Eugia Pharma Speclts
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma Speclts | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 065499-003 | Aug 17, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma Speclts | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 210735-002 | Aug 25, 2021 | RX | Yes | Yes | 9,662,342 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Eugia Pharma Speclts | METHOTREXATE SODIUM PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 201529-004 | Mar 29, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Eugia Pharma Speclts | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 065499-004 | Aug 17, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma Speclts | METHOTREXATE SODIUM PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 201529-001 | Mar 29, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Eugia Pharma Speclts | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 091613-002 | Dec 26, 2012 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma Speclts | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 065493-001 | Aug 17, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eugia Pharma Speclts Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2016147362 | ⤷ Try a Trial |
| European Patent Office | 3139929 | ⤷ Try a Trial |
| Japan | 2017514924 | ⤷ Try a Trial |
| Japan | 6516831 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2015171460 | ⤷ Try a Trial |
| Australia | 2015256331 | ⤷ Try a Trial |
| Brazil | 112016026140 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eugia Pharma Speclts Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0257344 | SPC/GB98/043 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DIPYRIDAMOLE, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY ACCEPTABLE SALT, AND O-ACETYLSALICYLIC ACID, OPTIONALLY IN THE FORM OF A PHYSIOLOGICALLY SALT, I.E. ASASANTIN RETARD; REGISTERED: FR NL 22160 19970709; UK 00015/0224 19980512 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
